Prescription of oral antidiabetics in Mexico. A cross-sectional study

In 2016 diabetes was declared an epidemic and a health emergency in Mexico. As the rationale of the treatment is to achieve target glycemia levels, the appropriateness of the medications used is important. The aim of this study is to learn the pattern of antidiabetic drug prescription and factors as...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2023-07, Vol.18 (7), p.e0288699-e0288699
Main Authors: Fierro, Inmaculada, Gallardo-Mora, Osiel, Alba-Leonel, Adela, Carvajal, Alfonso, Molina-Guarneros, Juan Arcadio
Format: Article
Language:English
Subjects:
Age
Antidiabetics
Biology and Life Sciences
Blood glucose
Body mass index
Committees
Complications and side effects
Contraindications
Cross-Sectional Studies
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - epidemiology
Diagnosis
Dosage and administration
Drug Prescriptions
Drugs
Epidemics
Ethics
Evaluation
Hospitals
Humans
Hypoglycemic agents
Hypoglycemic Agents - therapeutic use
Insulin
Medicine and Health Sciences
Metformin
Mexico - epidemiology
Morbidity
Mortality
Nutrition assessment
Obesity
Overweight
Patient outcomes
Patients
People and places
Population
Prescription drugs
Prescription writing
Retrospective Studies
Type 2 diabetes
Womens health
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c509t-6418c6eb8b18abf2f6da5f8924959ea423f7ae38ecdfb27e9556737bd8f65b033
container_end_page e0288699
container_issue 7
container_start_page e0288699
container_title PloS one
container_volume 18
creator Fierro, Inmaculada
Gallardo-Mora, Osiel
Alba-Leonel, Adela
Carvajal, Alfonso
Molina-Guarneros, Juan Arcadio
description In 2016 diabetes was declared an epidemic and a health emergency in Mexico. As the rationale of the treatment is to achieve target glycemia levels, the appropriateness of the medications used is important. The aim of this study is to learn the pattern of antidiabetic drug prescription and factors associated with inappropriate prescription in Mexico. A retrospective cross-sectional drug utilization study has been conducted. A randomly selected sample was carefully examined. Out of 3600 clinical records of patients diagnosed with type 2 diabetes mellitus (T2DM), 196 records were revised. As far as control is concerned, 36.7% had their glycemia values in the recommended range. A combination of different antidiabetics was the most common pattern observed (60.7%); the most frequent was that of the association of metformin with whatever oral antidiabetics. Prescriptions were considered as inappropriate in 149 cases (76.0%); younger age and lack of nutritional assessment was significantly related to inappropriate prescription. A trend to use more drugs for treating T2DM has been consistently observed. Despite using so many drugs, most of the patients are not controlled. Avoiding inappropriate prescription by following current guidelines may contribute to a better control and, in turn, decrease morbidity and mortality for this cause.
doi_str_mv 10.1371/journal.pone.0288699
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2842935481</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A758636426</galeid><sourcerecordid>A758636426</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-6418c6eb8b18abf2f6da5f8924959ea423f7ae38ecdfb27e9556737bd8f65b033</originalsourceid><addsrcrecordid>eNqFkl1rFDEUhgdRbK3-A9EBQfRi1nxMvq5kKVULlYpftyGTObObMpusSUbaf-9Md1p2RfAqgTzvOSfveYviOUYLTAV-dxWG6E2_2AYPC0Sk5Eo9KI6xoqTiBNGHe_ej4klKVwgxKjl_XBxRUSspsTguzr5ESDa6bXbBl6ErQzR9aXx2rTMNZGdT6Xz5Ga6dDYtyWdoYUqoS2EkwoikP7c3T4lFn-gTP5vOk-PHh7Pvpp-ri8uP56fKisgypXPEaS8uhkQ2WpulIx1vDOqlIrZgCUxPaCQNUgm27hghQjHFBRdPKjrMGUXpSvNzV3fYh6dmBpImsiaKslngk3s_E0GygteDz-CG9jW5j4o0OxunDF-_WehV-a4yooEpNPd7MFWL4NUDKeuOShb43HsJw26xGSmCmRvTVX-i_R3q7o1amB-28DT7DdV6ZISV9_u2rXgomOeU14f9hL38esq_32DWYPq9T6IdpMekQrHfg7e4idPd2YKSnLN2Nracs6TlLo-zFvpX3orvw0D_m_8Xb</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2842935481</pqid></control><display><type>article</type><title>Prescription of oral antidiabetics in Mexico. A cross-sectional study</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Fierro, Inmaculada ; Gallardo-Mora, Osiel ; Alba-Leonel, Adela ; Carvajal, Alfonso ; Molina-Guarneros, Juan Arcadio</creator><creatorcontrib>Fierro, Inmaculada ; Gallardo-Mora, Osiel ; Alba-Leonel, Adela ; Carvajal, Alfonso ; Molina-Guarneros, Juan Arcadio</creatorcontrib><description>In 2016 diabetes was declared an epidemic and a health emergency in Mexico. As the rationale of the treatment is to achieve target glycemia levels, the appropriateness of the medications used is important. The aim of this study is to learn the pattern of antidiabetic drug prescription and factors associated with inappropriate prescription in Mexico. A retrospective cross-sectional drug utilization study has been conducted. A randomly selected sample was carefully examined. Out of 3600 clinical records of patients diagnosed with type 2 diabetes mellitus (T2DM), 196 records were revised. As far as control is concerned, 36.7% had their glycemia values in the recommended range. A combination of different antidiabetics was the most common pattern observed (60.7%); the most frequent was that of the association of metformin with whatever oral antidiabetics. Prescriptions were considered as inappropriate in 149 cases (76.0%); younger age and lack of nutritional assessment was significantly related to inappropriate prescription. A trend to use more drugs for treating T2DM has been consistently observed. Despite using so many drugs, most of the patients are not controlled. Avoiding inappropriate prescription by following current guidelines may contribute to a better control and, in turn, decrease morbidity and mortality for this cause.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0288699</identifier><identifier>PMID: 37498817</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Age ; Antidiabetics ; Biology and Life Sciences ; Blood glucose ; Body mass index ; Committees ; Complications and side effects ; Contraindications ; Cross-Sectional Studies ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - epidemiology ; Diagnosis ; Dosage and administration ; Drug Prescriptions ; Drugs ; Epidemics ; Ethics ; Evaluation ; Hospitals ; Humans ; Hypoglycemic agents ; Hypoglycemic Agents - therapeutic use ; Insulin ; Medicine and Health Sciences ; Metformin ; Mexico - epidemiology ; Morbidity ; Mortality ; Nutrition assessment ; Obesity ; Overweight ; Patient outcomes ; Patients ; People and places ; Population ; Prescription drugs ; Prescription writing ; Retrospective Studies ; Type 2 diabetes ; Womens health</subject><ispartof>PloS one, 2023-07, Vol.18 (7), p.e0288699-e0288699</ispartof><rights>Copyright: © 2023 Fierro et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2023 Public Library of Science</rights><rights>2023 Fierro et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 Fierro et al 2023 Fierro et al</rights><rights>2023 Fierro et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c509t-6418c6eb8b18abf2f6da5f8924959ea423f7ae38ecdfb27e9556737bd8f65b033</cites><orcidid>0000-0003-4423-4493</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2842935481/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2842935481?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37498817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fierro, Inmaculada</creatorcontrib><creatorcontrib>Gallardo-Mora, Osiel</creatorcontrib><creatorcontrib>Alba-Leonel, Adela</creatorcontrib><creatorcontrib>Carvajal, Alfonso</creatorcontrib><creatorcontrib>Molina-Guarneros, Juan Arcadio</creatorcontrib><title>Prescription of oral antidiabetics in Mexico. A cross-sectional study</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>In 2016 diabetes was declared an epidemic and a health emergency in Mexico. As the rationale of the treatment is to achieve target glycemia levels, the appropriateness of the medications used is important. The aim of this study is to learn the pattern of antidiabetic drug prescription and factors associated with inappropriate prescription in Mexico. A retrospective cross-sectional drug utilization study has been conducted. A randomly selected sample was carefully examined. Out of 3600 clinical records of patients diagnosed with type 2 diabetes mellitus (T2DM), 196 records were revised. As far as control is concerned, 36.7% had their glycemia values in the recommended range. A combination of different antidiabetics was the most common pattern observed (60.7%); the most frequent was that of the association of metformin with whatever oral antidiabetics. Prescriptions were considered as inappropriate in 149 cases (76.0%); younger age and lack of nutritional assessment was significantly related to inappropriate prescription. A trend to use more drugs for treating T2DM has been consistently observed. Despite using so many drugs, most of the patients are not controlled. Avoiding inappropriate prescription by following current guidelines may contribute to a better control and, in turn, decrease morbidity and mortality for this cause.</description><subject>Age</subject><subject>Antidiabetics</subject><subject>Biology and Life Sciences</subject><subject>Blood glucose</subject><subject>Body mass index</subject><subject>Committees</subject><subject>Complications and side effects</subject><subject>Contraindications</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diagnosis</subject><subject>Dosage and administration</subject><subject>Drug Prescriptions</subject><subject>Drugs</subject><subject>Epidemics</subject><subject>Ethics</subject><subject>Evaluation</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypoglycemic agents</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Insulin</subject><subject>Medicine and Health Sciences</subject><subject>Metformin</subject><subject>Mexico - epidemiology</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Nutrition assessment</subject><subject>Obesity</subject><subject>Overweight</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>People and places</subject><subject>Population</subject><subject>Prescription drugs</subject><subject>Prescription writing</subject><subject>Retrospective Studies</subject><subject>Type 2 diabetes</subject><subject>Womens health</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqFkl1rFDEUhgdRbK3-A9EBQfRi1nxMvq5kKVULlYpftyGTObObMpusSUbaf-9Md1p2RfAqgTzvOSfveYviOUYLTAV-dxWG6E2_2AYPC0Sk5Eo9KI6xoqTiBNGHe_ej4klKVwgxKjl_XBxRUSspsTguzr5ESDa6bXbBl6ErQzR9aXx2rTMNZGdT6Xz5Ga6dDYtyWdoYUqoS2EkwoikP7c3T4lFn-gTP5vOk-PHh7Pvpp-ri8uP56fKisgypXPEaS8uhkQ2WpulIx1vDOqlIrZgCUxPaCQNUgm27hghQjHFBRdPKjrMGUXpSvNzV3fYh6dmBpImsiaKslngk3s_E0GygteDz-CG9jW5j4o0OxunDF-_WehV-a4yooEpNPd7MFWL4NUDKeuOShb43HsJw26xGSmCmRvTVX-i_R3q7o1amB-28DT7DdV6ZISV9_u2rXgomOeU14f9hL38esq_32DWYPq9T6IdpMekQrHfg7e4idPd2YKSnLN2Nracs6TlLo-zFvpX3orvw0D_m_8Xb</recordid><startdate>20230727</startdate><enddate>20230727</enddate><creator>Fierro, Inmaculada</creator><creator>Gallardo-Mora, Osiel</creator><creator>Alba-Leonel, Adela</creator><creator>Carvajal, Alfonso</creator><creator>Molina-Guarneros, Juan Arcadio</creator><general>Public Library of Science</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4423-4493</orcidid></search><sort><creationdate>20230727</creationdate><title>Prescription of oral antidiabetics in Mexico. A cross-sectional study</title><author>Fierro, Inmaculada ; Gallardo-Mora, Osiel ; Alba-Leonel, Adela ; Carvajal, Alfonso ; Molina-Guarneros, Juan Arcadio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-6418c6eb8b18abf2f6da5f8924959ea423f7ae38ecdfb27e9556737bd8f65b033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age</topic><topic>Antidiabetics</topic><topic>Biology and Life Sciences</topic><topic>Blood glucose</topic><topic>Body mass index</topic><topic>Committees</topic><topic>Complications and side effects</topic><topic>Contraindications</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diagnosis</topic><topic>Dosage and administration</topic><topic>Drug Prescriptions</topic><topic>Drugs</topic><topic>Epidemics</topic><topic>Ethics</topic><topic>Evaluation</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypoglycemic agents</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Insulin</topic><topic>Medicine and Health Sciences</topic><topic>Metformin</topic><topic>Mexico - epidemiology</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Nutrition assessment</topic><topic>Obesity</topic><topic>Overweight</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>People and places</topic><topic>Population</topic><topic>Prescription drugs</topic><topic>Prescription writing</topic><topic>Retrospective Studies</topic><topic>Type 2 diabetes</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fierro, Inmaculada</creatorcontrib><creatorcontrib>Gallardo-Mora, Osiel</creatorcontrib><creatorcontrib>Alba-Leonel, Adela</creatorcontrib><creatorcontrib>Carvajal, Alfonso</creatorcontrib><creatorcontrib>Molina-Guarneros, Juan Arcadio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Hospital Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection (ProQuest)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Database (Proquest)</collection><collection>ProQuest Central</collection><collection>Technology collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fierro, Inmaculada</au><au>Gallardo-Mora, Osiel</au><au>Alba-Leonel, Adela</au><au>Carvajal, Alfonso</au><au>Molina-Guarneros, Juan Arcadio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prescription of oral antidiabetics in Mexico. A cross-sectional study</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2023-07-27</date><risdate>2023</risdate><volume>18</volume><issue>7</issue><spage>e0288699</spage><epage>e0288699</epage><pages>e0288699-e0288699</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>In 2016 diabetes was declared an epidemic and a health emergency in Mexico. As the rationale of the treatment is to achieve target glycemia levels, the appropriateness of the medications used is important. The aim of this study is to learn the pattern of antidiabetic drug prescription and factors associated with inappropriate prescription in Mexico. A retrospective cross-sectional drug utilization study has been conducted. A randomly selected sample was carefully examined. Out of 3600 clinical records of patients diagnosed with type 2 diabetes mellitus (T2DM), 196 records were revised. As far as control is concerned, 36.7% had their glycemia values in the recommended range. A combination of different antidiabetics was the most common pattern observed (60.7%); the most frequent was that of the association of metformin with whatever oral antidiabetics. Prescriptions were considered as inappropriate in 149 cases (76.0%); younger age and lack of nutritional assessment was significantly related to inappropriate prescription. A trend to use more drugs for treating T2DM has been consistently observed. Despite using so many drugs, most of the patients are not controlled. Avoiding inappropriate prescription by following current guidelines may contribute to a better control and, in turn, decrease morbidity and mortality for this cause.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>37498817</pmid><doi>10.1371/journal.pone.0288699</doi><tpages>e0288699</tpages><orcidid>https://orcid.org/0000-0003-4423-4493</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2023-07, Vol.18 (7), p.e0288699-e0288699
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2842935481
source Publicly Available Content Database; PubMed Central
subjects Age
Antidiabetics
Biology and Life Sciences
Blood glucose
Body mass index
Committees
Complications and side effects
Contraindications
Cross-Sectional Studies
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - epidemiology
Diagnosis
Dosage and administration
Drug Prescriptions
Drugs
Epidemics
Ethics
Evaluation
Hospitals
Humans
Hypoglycemic agents
Hypoglycemic Agents - therapeutic use
Insulin
Medicine and Health Sciences
Metformin
Mexico - epidemiology
Morbidity
Mortality
Nutrition assessment
Obesity
Overweight
Patient outcomes
Patients
People and places
Population
Prescription drugs
Prescription writing
Retrospective Studies
Type 2 diabetes
Womens health
title Prescription of oral antidiabetics in Mexico. A cross-sectional study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-07T14%3A41%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prescription%20of%20oral%20antidiabetics%20in%20Mexico.%20A%20cross-sectional%20study&rft.jtitle=PloS%20one&rft.au=Fierro,%20Inmaculada&rft.date=2023-07-27&rft.volume=18&rft.issue=7&rft.spage=e0288699&rft.epage=e0288699&rft.pages=e0288699-e0288699&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0288699&rft_dat=%3Cgale_plos_%3EA758636426%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c509t-6418c6eb8b18abf2f6da5f8924959ea423f7ae38ecdfb27e9556737bd8f65b033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2842935481&rft_id=info:pmid/37498817&rft_galeid=A758636426&rfr_iscdi=true